Back to Deals
No Image Provided
Summary
In a significant market movement during February 2011, CellNovo was the subject of a vc funding. The transaction achieved a gross valuation of £30,000,000. Leading the round was Advent Venture Partners, Forbion Capital Partners, NESTA Investments, NBGI Ventures.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Related Deals in Healthcare & Biotech
Series B prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in